Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cells

Edward L. Schwartz, Mark Hoffman, Carolyn J. O'Connor, Scott Wadler

Research output: Contribution to journalArticle

123 Scopus citations

Abstract

Interferon-α (IFNα) increases the cytotoxicity of 5-fluorouracil (FUra) in vitro, and the combination has clinical efficacy against advanced colorectal cancer. IFNα treatment of HT-29 colon carcinoma cells induced a greater than two-fold increase in the intracellular levels of the active metabolite of FUra, FdUMP. Using cell extracts from HT-29 cells and FUra as substrate, IFNα produced a 1.9- and 8.7-fold increase, respectively, in the activities of uridine phosphorylase and pyrimidine nucleoside phosphorylase (PyNP). Furthermore, the effect was selective for the conversion of FUra to FdUMP, as IFNα did not increase the cellular levels of FUTP, nor did it change the extent of incorporation of FUra into RNA (or DNA). IFNα also had no effect on thymidine kinase activity, the second step in the activation of FUra. Hence the effect of IFNα on PyNP activity is likely a critical biochemical event that modulates the cytotoxicity of FUra.

Original languageEnglish (US)
Pages (from-to)1232-1239
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume182
Issue number3
DOIs
Publication statusPublished - Feb 14 1992

    Fingerprint

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this